老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
高瓴概念
452.224
-3.631
-0.80%
手動刷新
漲家數：
20
跌家數：
28
平家數：
3
市盈率：
- -
高：
458.741
開：
455.974
低：
450.554
收：
455.854
成交量：
3.00億
成交額：
63.50億
市值：
2.88萬億
流通市值：
1.99萬億
資料載入中...
總覽
新聞資訊
小摩：金斯瑞生物科技(01548.HK)配售後股價逆市上揚 重申「增持」評級
智通财经
·
09/14
港股異動 | 翰森製藥(03692)漲近4% 瑞康立伏妥塔單抗的中位OS達到18.5個月
智通财经
·
09/14
特步國際(01368)股價上升5.023%，現價港幣$3.45
阿斯达克财经
·
09/14
港股異動 | 泰格醫藥(03347.HK)升逾7% 花旗指監管不確定性消除 對公司訂單增長及盈利可見度維持正面
智通财经
·
09/14
港股異動 | CRO概念股漲幅居前、凱萊英大漲12%，中報持續驗證行業高景氣，多家公司上調業績指引
智通财经
·
09/14
港股異動 | 金斯瑞生物科技(01548.HK)早盤升逾5% 小摩認為市場仍對金斯瑞AIDD業務興趣濃厚
智通财经
·
09/14
「超30家藥企長期行賄」，涉案醫院回應
澎湃新闻
·
09/14
翰森製藥(03692.HK)升逾3% 富瑞：Ris-Rez公布具里程碑意義總生存期數據
阿斯达克财经
·
09/14
大行評級丨花旗：泰格醫藥監管不確定性消除，重申「買入」評級及首選股地位
格隆汇
·
09/14
《股市簡訊》中國火鍋連鎖店海底撈挫2.9%，花旗稱8月每周翻台率波動大於預期
路透中文
·
09/14
港股異動 | 海底撈(06862)跌近3% 8月翻台率表現遜於預期 近日創始人妻子折價套現或加重市場負面情緒
智通财经
·
09/14
《大行》摩通：「後預售時代」不確定性拖累未來數月內房商或跑輸大市 明年合約銷售或跌逾20%
阿斯达克财经
·
09/14
大行評級丨花旗：海底撈8月翻台率跌低單位數遜預期，維持「買入」評級
格隆汇
·
09/14
信義能源(03868)出現大手買入200萬股，成交價$0.78，涉資156萬
阿斯达克财经
·
09/14
《大行》花旗：海底撈(06862.HK)8月翻台率跌低單位數遜預期 大股東減持增負面情緒
阿斯达克财经
·
09/14
大行評級丨高盛：CRO/CDMO行業復甦步伐明確，看好藥明康德、藥明合聯等
格隆汇
·
09/14
CRO概念股早盤漲幅居前 凱萊英漲逾9%泰格醫藥漲逾7%
新浪港股
·
09/14
藥明康德(02359)出現大手賣出5.95萬股，成交價$195.2，涉資1.161千萬
阿斯达克财经
·
09/14
醫藥板塊表現強勢 凱萊英（06821）升逾5% 機構制AI製藥商業化風口初步顯現
金吾财讯
·
09/14
泰格醫藥(03347.HK)董事長及執董遭中證監警告及各罰50萬人幣
阿斯达克财经
·
09/14
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BK1583/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":452.22354,"timestamp":1789546124622,"preClose":455.85437,"halted":0,"volume":299993995,"delay":0,"changeRate":-0.007965,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-3.630829,"latestTime":"09-16 16:00:00","open":455.97388,"high":458.74115,"low":450.55423,"amount":6350408240.5,"amplitude":0.01796,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":2.069963,"peRate":43.726837,"turnoverRate":0.002722,"increases":19,"decrements":29,"flats":1,"marketCap":2875189263312,"floatMarketCap":1990396956112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":458.74115,"amplitude":0.01796,"preClose":455.85437,"low":450.55423,"pbRate":"2.069963","latestPrice":452.22354,"volume":299993995,"delay":0,"open":455.97388,"prevYearClose":503.90085,"prevWeekClose":450.903,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":466.322,"twentyDayClose":485.91,"sixtyDayClose":397.333,"secType":"PLATE","market":"HK","turnoverRate":0.002722,"peRate":43.726837,"marketCap":2875189263312,"floatMarketCap":1990396956112,"timestamp":1789546124622,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":20,"down":28,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667658624","title":"小摩：金斯瑞生物科技(01548.HK)配售後股價逆市上揚 重申「增持」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658624","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667658624?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:06","pubTimestamp":1789365984,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01548","BK1576","HK0000306685.HKD","HK0000320223.HKD","BK1141","HK0000306701.USD","BK1583","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667630269","title":"港股異動 | 翰森製藥(03692)漲近4% 瑞康立伏妥塔單抗的中位OS達到18.5個月","url":"https://stock-news.laohu8.com/highlight/detail?id=2667630269","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667630269?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:58","pubTimestamp":1789365528,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，翰森制药涨近4%，截至发稿，涨3.73%，报33.94港元，成交额2.05亿港元。消息面上，9月13日，翰森制药在2026世界肺癌大会首场主席论坛上，以最新突破性摘要形式口头报告自研B7-H3靶向ADC——瑞康立伏妥塔单抗的III期ARTEMIS-008研究期中结果。这次公布的数据，瑞康立伏妥塔单抗刷新了小细胞肺癌二线治疗最长总生存期纪录。具体看，瑞康立伏妥塔单抗的中位OS达到18.5个月，而托泊替康的中位OS是10.3个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","KCAI","03692","BK4588","VXUS","BK1191","BK4585","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667630095","title":"特步國際(01368)股價上升5.023%，現價港幣$3.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2667630095","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667630095?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:50","pubTimestamp":1789365000,"startTime":"0","endTime":"0","summary":"[上升股]特步国际(01368) 股价在下午01:49比前收市价上升5.023%，现股价为港币$3.45。至目前为止，今日最高价为$3.45，而最低价为$3.295。总成交量为1.18千万股，总成交金额为港币$4.012千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609141447/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609141447/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","01368","LU0702159343.USD","BK1168","LU1166156734.SGD","LU0702159699.USD","BK1512","BK1502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663055","title":"港股異動 | 泰格醫藥(03347.HK)升逾7% 花旗指監管不確定性消除 對公司訂單增長及盈利可見度維持正面","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663055","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663055?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:42","pubTimestamp":1789364551,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","03347","BK1583","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667763172","title":"港股異動 | CRO概念股漲幅居前、凱萊英大漲12%，中報持續驗證行業高景氣，多家公司上調業績指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2667763172","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667763172?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:34","pubTimestamp":1789364090,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股涨幅居前，截至发稿，凯莱英涨5.89%，报142.1港元；康龙化成涨4.72%，报28.84港元；泰格医药涨4.64%，报43.32港元；药明生物涨2.30%，报48.08港元。消息面上，国内外CXO公司中报业绩持续验证行业高景气。国内药明康德发布中报，业绩大幅超市场预期，同时大幅上调全年业绩指引。该行表示，看好药明系、康龙化成、凯莱英、泰格医药及金斯瑞。","market":"sh","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495468.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | CRO概念股涨幅居前，中报持续验证行业高景气，多家公司上调业绩指引","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1610","BK1521","BK1141","LU0326950275.SGD","LU1720050803.USD","02269","SG9999002463.SGD","LU0029874061.USD","06821","LU0823426308.USD","LU0979878070.USD","LU0181495838.USD","LU0823426480.USD","03347","LU0417516738.SGD","LU0456827905.SGD","LU2039709279.SGD","LU0561508036.HKD","LU0039217434.USD","BK1589","LU0819121731.USD","LU0348735423.USD","BK1191","KURE","LU1688375341.USD","LU3063872942.SGD","BK4588","LU0140636845.USD","LU0359201612.USD","LU0516423091.SGD","03759","LU0320764599.SGD","LU1880383366.USD","LU0588546209.SGD","KCAI","LU0456846285.SGD","LU0516423174.USD","LU0327786744.USD","LU0516422366.SGD","LU0307460666.USD","LU0348825331.USD","LU0856984785.SGD","LU0359202008.SGD","LU0516422952.EUR","LU0572944931.SGD","BK1583","LU0051755006.USD","LU0348827113.USD","LU0128526141.USD","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667463291","title":"港股異動 | 金斯瑞生物科技(01548.HK)早盤升逾5% 小摩認為市場仍對金斯瑞AIDD業務興趣濃厚","url":"https://stock-news.laohu8.com/highlight/detail?id=2667463291","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667463291?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:48","pubTimestamp":1789357729,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HK0000320223.HKD","BK1141","BK1576","01548","HK0000306701.USD","HK0000306685.HKD","BK1583","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667863208","title":"「超30家藥企長期行賄」，涉案醫院回應","url":"https://stock-news.laohu8.com/highlight/detail?id=2667863208","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667863208?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:36","pubTimestamp":1789356960,"startTime":"0","endTime":"0","summary":"澎湃新闻首席记者 李潇潇9月13日，国家医保局发布《医疗机构涉医药购销商业贿赂案》一文提到，仅2025年下半年，河北医科大学第二医院就涉及9件司法刑事判决。在国家医保局9月13日最新披露的信息中，有超过30家医药企业长期对河北医科大学第二医院工作人员行贿。具体到河北祥恩医疗器械贸易有限公司一家，该公司为向河北医科大学第二医院销售价格虚高的医疗耗材，累计向该医院工作人员行贿2064万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-09-14/doc-iniruhxa7301443.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-14/doc-iniruhxa7301443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MEDX","MDEV","AGNG","IEIH","PTH","RSPH","09996","BK1100","GDOC","HART","LNGR","BK1583","BK1574","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629632","title":"翰森製藥(03692.HK)升逾3% 富瑞：Ris-Rez公布具里程碑意義總生存期數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629632","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629632?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:33","pubTimestamp":1789356780,"startTime":"0","endTime":"0","summary":"翰森制药今日高开0.55%，最高见34.08元。现报33.78元，升3.24%，成交452.85万股，涉资1.52亿元。富瑞报告指，翰森制药旗下Ris-Rez在WCLC 2026主席论坛以Late-Breaking Oral形式公布ARTEMIS-008三期中期结果，对比topotecan治疗铂类预处理后复发小细胞肺癌，达到主要终点，带来具统计学意义及临床意义的总生存期获益。该行认为，数据质素被低估，对Ris-Rez潜在同类最佳轮廓有信心，并有望进一步扩展至更早线治疗。该行维持翰森制药“买入”评级及目标价50元，较前一交易日收市价32.72元有53%上行空间。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20201021164015908_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20201021164015908_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544261/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544261/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1589","BK1583","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667634068","title":"大行評級丨花旗：泰格醫藥監管不確定性消除，重申「買入」評級及首選股地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2667634068","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667634068?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:25","pubTimestamp":1789356347,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1146622755.USD","BK1576","LU1820825898.SGD","BK1583","BK0028","BK0077","BK1141","BK0174","BK0216","300347","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667634735","title":"《股市簡訊》中國火鍋連鎖店海底撈挫2.9%，花旗稱8月每周翻台率波動大於預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2667634735","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667634735?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:18","pubTimestamp":1789355886,"startTime":"0","endTime":"0","summary":"《股市简讯》中国火锅连锁店海底捞挫2.9%，花旗称8月每周翻台率波动大于预期* 中国火锅连锁店--海底捞6862.HK周一早盘挫2.9%，创四年半新低。* 花旗研报指出，海底捞8月每周翻台率波动幅度大于预期，反映出中国整体消费环境仍较疲软；另于9月8日，其控股股东成员之一以每股10.62港元出售了约4.7%的海底捞股份，进一步加重了市场对该股的负面情绪。* 海底捞今年迄今跌30.5%，同期恒生指数.HSI下滑2.9%。（完）更多股市简讯请点选CN-CMN-HOT","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4S456068:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU2488822045.USD","BK1233","BK1583","BK1604","06862","BK1591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667340576","title":"港股異動 | 海底撈(06862)跌近3% 8月翻台率表現遜於預期 近日創始人妻子折價套現或加重市場負面情緒","url":"https://stock-news.laohu8.com/highlight/detail?id=2667340576","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667340576?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:17","pubTimestamp":1789355835,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，海底捞跌近3%，截至发稿，跌1.79%，报9.88港元，成交额1.25亿港元。消息面上，花旗发布指出，据海底捞与投资者沟通，公司8月全月翻台率按年下跌低个位数，对比管理层于上半年业绩后指8月首三周翻台率按年升低个位数，表现逊于预期。该行认为，8月每周翻台率波幅大于预期，反映中国整体消费环境偏软。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK4588","BK1233","VXUS","BK1591","LU2488822045.USD","BK1589","06862","BK1604","BK4585","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667059634","title":"《大行》摩通：「後預售時代」不確定性拖累未來數月內房商或跑輸大市 明年合約銷售或跌逾20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667059634","media":"阿斯达克财经","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667059634?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:14","pubTimestamp":1789355640,"startTime":"0","endTime":"0","summary":"摩根大通发表研究报告指，内地当局上月28日推出一系列住房销售制度改革措施，预期市场需要时间消化中国房地产行业“后预售”时代所带来的潜在销售重置，由于目前欠缺明确催化剂，相信未来数月内房发展商表现将跑输大市。摩通预测，若828新政严格执行，内房2027年合约销售将跌20%至30%，假设利润率水平未变，2029年盈利预期出现相若跌幅，当内房板块市账率回落至低位时，股价可能有约10%至20%潜在下行空间。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180509171358503_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180509171358503_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544252/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544252/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0561508036.HKD","LU0359201612.USD","HK0000306685.HKD","LU0791591158.USD","00817","LU0516423174.USD","LU1880383366.USD","LU0620787316.HKD","LU1242518931.SGD","BK1521","LU1993786604.SGD","LU0348825331.USD","LU2476274308.USD","LU0979878070.USD","LU0048597586.USD","01209","LU0072913022.USD","LU0051755006.USD","LU0164939612.USD","IE00B3M56506.USD","02423","HK0000320264.USD","LU2088748293.HKD","LU3063872942.SGD","LU2778985437.USD","LU0501845795.SGD","LU0359202008.SGD","IE0008368742.USD","LU0650527681.SGD","BK1542","01109","LU0516422440.USD","LU2088748020.USD","LU0516422952.EUR","BK1555","LU0414403682.SGD","BK1240","LU0082770016.USD","LU1152091754.HKD","LU1366334578.USD","LU0264606111.USD","LU0516422366.SGD","LU2088748376.SGD","BK1583","LU0456846285.SGD","00960","LU0605514214.HKD","LU0173614495.USD","HK0000306701.USD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667634485","title":"大行評級丨花旗：海底撈8月翻台率跌低單位數遜預期，維持「買入」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2667634485","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667634485?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:05","pubTimestamp":1789355146,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1591","BK1589","BK1604","06862","LU2488822045.USD","BK1233","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667363427","title":"信義能源(03868)出現大手買入200萬股，成交價$0.78，涉資156萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2667363427","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667363427?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:54","pubTimestamp":1789354440,"startTime":"0","endTime":"0","summary":"[大手成交]信义能源(03868)在上午10:54出现大手买入，成交量为200万，成交价为港币$0.78，涉资156万。至目前为止，股价跌2.516%，今日最高价为$0.8，而最低价为$0.775，总成交量为366.606万股，总成交金额港币$286.356万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609145167/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609145167/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1594","BK1154","03868","BK1583","BK1554"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667634179","title":"《大行》花旗：海底撈(06862.HK)8月翻台率跌低單位數遜預期 大股東減持增負面情緒","url":"https://stock-news.laohu8.com/highlight/detail?id=2667634179","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667634179?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:53","pubTimestamp":1789354380,"startTime":"0","endTime":"0","summary":"花旗发表研究报告指，据海底捞与投资者沟通，公司8月全月翻台率按年下跌低个位数，对比管理层于上半年业绩后指8月首三周翻台率按年升低个位数，表现逊预期。该行认为，8月每周翻台率波幅大于预期，反映中国整体消费环境偏软。报告指，9月8日，控股股东成员舒萍出售约2.59亿股、相当于约4.7%股权，进一步加重了市场对该股的负面情绪。出售后控股股东合计持股由约50.2%降至约45.5%。该行维持海底捞“买入”评级及目标价19.3元。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250303142644269_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250303142644269_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544243/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544243/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1591","BK1589","BK1604","06862","LU2488822045.USD","BK1233","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667634555","title":"大行評級丨高盛：CRO/CDMO行業復甦步伐明確，看好藥明康德、藥明合聯等","url":"https://stock-news.laohu8.com/highlight/detail?id=2667634555","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667634555?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:43","pubTimestamp":1789353837,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0708995583.HKD","LU2045819591.USD","LU1188198961.HKD","LU0244354667.USD","LU0348766576.USD","LU2488822045.USD","LU0052750758.USD","LU0327786744.USD","LU0463099449.HKD","LU1046422090.SGD","SG9999014674.SGD","BK1141","LU0348767384.USD","BK1576","LU2242644610.SGD","BK1583","02268","LU0469268626.HKD","LU0326950275.SGD","LU0572944931.SGD","LU2125910500.SGD","02359","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667063438","title":"CRO概念股早盤漲幅居前 凱萊英漲逾9%泰格醫藥漲逾7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667063438","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667063438?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:39","pubTimestamp":1789353540,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端CRO概念股早盘涨幅居前，截至发稿，凯莱英（06821）上涨8.87%，报146.10港元；泰格医药（03347）上涨7.01%，报44.30港元；康龙化成（03759）上涨6.54%，报29.34港元；药明生物（02269）上涨3.62%，报48.70港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-14/doc-iniruark4855815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1328615791.USD","BK1583","BK0132","06821","BK0216","BK1191","BK1576","BK0239","300347","BK1141","03347","BK0077","LU1146622755.USD","BK0174","LU1820825898.SGD","002821","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667634619","title":"藥明康德(02359)出現大手賣出5.95萬股，成交價$195.2，涉資1.161千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2667634619","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667634619?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:29","pubTimestamp":1789352940,"startTime":"0","endTime":"0","summary":"[大手成交]药明康德(02359)在上午10:29出现大手卖出，成交量为5.95万，成交价为港币$195.2，涉资1.161千万。至目前为止，股价升3.496%，今日最高价为$196.1，而最低价为$186.0，总成交量为91.852万股，总成交金额港币$1.758亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609143622/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609143622/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2495084118.USD","LU0456842615.SGD","LU0469268626.HKD","LU1251922891.USD","LU1997245094.SGD","LU1770034418.SGD","LU0572944931.SGD","LU1934453819.USD","LU2045819591.USD","BK1576","IE00BPRC5H50.USD","LU0348767384.USD","LU0611395673.USD","LU0320764599.SGD","LU1808992512.USD","LU1969619763.USD","LU2328871848.SGD","LU0052750758.USD","02359","LU2488822045.USD","603259","BK1583","LU2125910500.SGD","IE00B5MMRT66.SGD","LU1046422090.SGD","LU1979443071.USD","LU0700851271.USD","LU1719994722.HKD","LU1997244956.HKD","LU0708995583.HKD","BK0216","LU2242644610.SGD","LU0348766576.USD","LU1997245177.USD","LU1303224171.USD","BK1141","IE00B543WZ88.USD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667083631","title":"醫藥板塊表現強勢 凱萊英（06821）升逾5% 機構制AI製藥商業化風口初步顯現","url":"https://stock-news.laohu8.com/highlight/detail?id=2667083631","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667083631?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:26","pubTimestamp":1789352818,"startTime":"0","endTime":"0","summary":"消息面上，招商证券指出，自2024年以来，AI制药发展速度明显加快，投资规模和项目数量显著增长。跨国药企开始大规模搭建自有AI平台能力，合作模式由单点项目合作转向管线与平台层面深度合作。AI科技巨头入局药物研发领域，依托通用大模型推出面向药物研发的专用AI模型。AI Biotech的合作机会与交易规模持续扩容，即便尚未拥有成熟商业化管线，也获得传统药企青睐。AI制药行业已完成概念验证，正式迈入临床验证阶段，商业化风口初步显现。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991473","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052750758.USD","LU1328615791.USD","LU1880383366.USD","LU1046422090.SGD","159938","09939","KURE","LU0979878070.USD","LU2242644610.SGD","LU1720050803.USD","CHAT","002821","LU0823426480.USD","LU0588546209.SGD","01477","IE00B0JY6N72.USD","AGIX","LU0516423174.USD","VTHR","BK0239","03347","03759","AIPO","BK1191","LU0359201612.USD","LU2125910500.SGD","QTOC","LU1242518857.USD","BK1583","LU0417516902.SGD","LU0128526141.USD","LU0307460666.USD","LU1688375341.USD","LU0326950275.SGD","06821","LU0516422440.USD","02269","BK1515","ARTY","SG9999002463.SGD","BK1141","LU0348766576.USD","LU0417516738.SGD","LU1242518931.SGD","LU0516422366.SGD","LU0043850808.USD","LU0819121731.USD","BK1610","02359","SG9999002562.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667634893","title":"泰格醫藥(03347.HK)董事長及執董遭中證監警告及各罰50萬人幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2667634893","media":"阿斯达克财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667634893?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:25","pubTimestamp":1789352700,"startTime":"0","endTime":"0","summary":"泰格医药公布，执行董事、董事长兼控股股东叶小平及执行董事曹晓春收到中国证监会浙江监管局对两人采取出具警示函措施及行政处罚事先告知，拟对两人给予警告，并各处以50万元人民币罚款。二人可于接获本决定之日起60日内向中国证监会提出行政覆议申请，或于接获警示函之日起6个月内向有管辖权的人民法院提起诉讼。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210301160531093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210301160531093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544226/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544226/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0028","LU1820825898.SGD","BK1576","03347","BK0216","BK1583","BK1141","BK0174","300347","LU1146622755.USD","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":26,"pageCount":7,"totalSize":501,"code":"91000000","status":"200"}]}}